Related Experiment Video

Updated: Aug 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C among drug users: consensus guidelines on management in general practice

J Barry1, M Bourke, M Buckley

  • 1Eastern Regional Health Authority.

Irish Journal of Medical Science
|February 8, 2005
PubMed

Insights

Guidelines were developed to help general practitioners (GPs) manage Hepatitis C (HCV) in patients receiving methadone treatment. These guidelines cover comprehensive care for HCV risk and infection in opiate users.

Area of Science:

  • Hepatology
  • Public Health
  • General Practice

Background:

  • Hepatitis C (HCV) infection presents a significant health challenge for patients undergoing methadone maintenance treatment.
  • General practitioners (GPs) in Ireland frequently encounter patients with HCV within this demographic.

Purpose of the Study:

  • To outline the creation and content of clinical guidelines for managing HCV in current or former opiate users.
  • Guidelines are specifically for patients attending GPs for methadone treatment in the Eastern Regional Health Authority area.

Main Methods:

  • A multi-stage approach was employed, including stakeholder identification and evidence-based guideline development.
  • Consensus was achieved through a Delphi-facilitated process, followed by review from a sample of intended GP users.

Main Results:

  • The developed guidelines offer comprehensive advice to GPs on managing patients at risk of HCV.
  • Guidance includes preventative care, management of co-infections (bloodborne and hepatotoxic viruses), and referral criteria for hepatology assessment.

Conclusions:

  • General practitioners are integral to the care pathway for patients at risk of or infected with HCV.
  • Effective management requires GPs to be equipped with specific, evidence-based guidelines.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...